These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16004839)

  • 1. Pain management, including intrathecal pumps.
    Smith TJ; Swainey C; Coyne PJ
    Curr Pain Headache Rep; 2005 Aug; 9(4):243-8. PubMed ID: 16004839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain management, including intrathecal pumps.
    Smith TJ; Swainey C; Coyne PJ
    Curr Oncol Rep; 2004 Jul; 6(4):291-6. PubMed ID: 15161583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients.
    Smith TJ; Coyne PJ
    J Palliat Med; 2005 Aug; 8(4):736-42. PubMed ID: 16128647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Smith TJ; Staats PS; Deer T; Stearns LJ; Rauck RL; Boortz-Marx RL; Buchser E; Català E; Bryce DA; Coyne PJ; Pool GE;
    J Clin Oncol; 2002 Oct; 20(19):4040-9. PubMed ID: 12351602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM).
    Smith TJ; Coyne PJ; Staats PS; Deer T; Stearns LJ; Rauck RL; Boortz-Marx RL; Buchser E; Català E; Bryce DA; Cousins M; Pool GE
    Ann Oncol; 2005 May; 16(5):825-33. PubMed ID: 15817596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
    Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
    Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an implantable drug delivery system for refractory chronic sickle cell pain.
    Smith TJ; Coyne PJ; Smith WR; Roberts JD; Smith V
    Am J Hematol; 2005 Feb; 78(2):153-4. PubMed ID: 15682408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intrathecal drug administration for chronic nonmalignant pain.
    Duarte RV; Raphael JH; Sparkes E; Southall JL; LeMarchand K; Ashford RL
    J Neurosurg Anesthesiol; 2012 Jan; 24(1):63-70. PubMed ID: 21904220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal therapy for chronic pain.
    Miles J
    Stereotact Funct Neurosurg; 2001; 77(1-4):156-8. PubMed ID: 12378067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the evidence for implantable drug delivery systems for refractory cancer pain?
    Smith TJ; Coyne P
    Support Cancer Ther; 2004 Apr; 1(3):185-9. PubMed ID: 18628140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices.
    Scanlon MM; Gazelka HM; Moeschler SM; Hoelzer BC; Hooten WM; Bendel MA; Lamer TJ
    Pain Med; 2017 Mar; 18(3):520-525. PubMed ID: 27550951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and Recent Advances in Targeted Drug Delivery for Cancer Pain: Is It Time to Change the Paradigm?
    Dupoiron D; Duarte R; Carvajal G; Aubrun F; Eldabe S
    Pain Physician; 2022 May; 25(3):E414-E425. PubMed ID: 35652767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal Drug Delivery Systems for Cancer Pain Control: Insights on Current Contemporary Practices in the US.
    Goel V; Kumar V; Blaes A; Gulati A
    Neuromodulation; 2023 Aug; 26(6):1256-1262. PubMed ID: 37318432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal therapy for cancer and non-cancer pain.
    Hayek SM; Deer TR; Pope JE; Panchal SJ; Patel VB
    Pain Physician; 2011; 14(3):219-48. PubMed ID: 21587327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of Hospice Providers Regarding Intrathecal Targeted Drug Delivery for Patients With Cancer.
    Warner LL; Moeschler SS; Pittelkow TP; Strand JJ
    Am J Hosp Palliat Care; 2019 Nov; 36(11):955-958. PubMed ID: 31132860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriology, drug stability and exchange of percutaneous delivery systems and antibacterial filters in long-term intrathecal infusion of opioid drugs and bupivacaine in "refractory" pain.
    Nitescu P; Hultman E; Appelgren L; Linder LE; Curelaru I
    Clin J Pain; 1992 Dec; 8(4):324-37. PubMed ID: 1493343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer.
    Sindt JE; Odell DW; Dalley AP; Brogan SE
    Neuromodulation; 2020 Oct; 23(7):978-983. PubMed ID: 32459393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis.
    Duarte R; Copley S; Nevitt S; Maden M; Al-Ali AM; Dupoiron D; Eldabe S
    Neuromodulation; 2023 Aug; 26(6):1126-1141. PubMed ID: 35422368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps.
    Dahm P; Nitescu P; Appelgren L; Curelaru I
    Clin J Pain; 1998 Mar; 14(1):4-16. PubMed ID: 9535309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.